EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salicylamides as RNA-Dependent RNA Polymerase Inhibitors with Antiviral Activity against West Nile and Zika Viruses

Natalia del Río, Álvaro Rodríguez-Tacón, Estela Escribano-Romero, Alejandra Álvarez-Mínguez, Marta Gargantilla, Flavia Caridi, Teresa Poderoso, Ernesto Quesada, Tereza Kauerová, Peter Kollár, Miguel A. Martín-Acebes, Eva-María Priego und 2 weitere

Journal of Medicinal Chemistry · 26.10.2026

DOI: 10.1021/acs.jmedchem.6c01236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.10.2026. Verfasst von Natalia del Río und 13 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Ministerio de Ciencia, Innovación y Universidades, NextGenerationEU.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mosquito-transmitted orthoflaviviruses constitute an escalating global threat to public health, for which no approved antiviral therapies exist. Here, we identify the salicylanilide derivative S1 as a West Nile virus (WNV) RNA-dependent RNA-polymerase (RdRp) inhibitor. Chemical optimization of S1 yielded compound S7, which inhibited WNV RdRp activity and displayed antiviral efficacy in Vero cells (EC50 of 3.0 μM; CC50 > 100 μM). S7 and related analogues inhibited Zika virus (ZIKV) RdRp, and this enzymatic inhibition translated into antiviral activity in cell-based assays. Compared with niclosamide, as reference salicylanilide, compound S7 exerted lower impact on mitochondria, reduced cytotoxicity and no induction of apoptosis. Molecular modelling support binding within the polymerase N-pocket, with key contributing residues being highly conserved in both WNV and ZIKV polymerases. Site-directed mutagenesis further supported the importance of N-pocket residues for S7 binding. Therefore, the S7-scaffold constitutes a promising antiviral chemotype against orthoflaviviruses.

Förderung

  • European Regional Development Fund
  • Ministerio de Ciencia, Innovación y Universidades
  • NextGenerationEU
  • Comunidad de Madrid

Zitieren

APA

Río, N. D., Rodríguez-Tacón, A., Escribano-Romero, E., Álvarez-Mínguez, A., Gargantilla, M., Caridi, F., Poderoso, T., Quesada, E., Kauerová, T., Kollár, P., Martín-Acebes, M. A., Priego, E., Agudo, R., & Pérez-Pérez, M. (2026). Salicylamides as RNA-Dependent RNA Polymerase Inhibitors with Antiviral Activity against West Nile and Zika Viruses. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01236

Vancouver

Río ND, Rodríguez-Tacón A, Escribano-Romero E, Álvarez-Mínguez A, Gargantilla M, Caridi F, et al. Salicylamides as RNA-Dependent RNA Polymerase Inhibitors with Antiviral Activity against West Nile and Zika Viruses. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01236

BibTeX
@article{Rio2026,
  author = {Río, Natalia del and Rodríguez-Tacón, Álvaro and Escribano-Romero, Estela and Álvarez-Mínguez, Alejandra and Gargantilla, Marta and Caridi, Flavia and Poderoso, Teresa and Quesada, Ernesto and Kauerová, Tereza and Kollár, Peter and Martín-Acebes, Miguel A. and Priego, Eva-María and Agudo, Rubén and Pérez-Pérez, María-Jesús},
  title = {Salicylamides as RNA-Dependent RNA Polymerase Inhibitors with Antiviral Activity against West Nile and Zika Viruses},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01236}
}
Kostenlos starten →